Primary biliary cirrhosis is a disease characterized by progressive destruction of bile ducts for unknown mechanisms. This editorial focuses on primary biliary cirrhosis clinical treatment, including the present strategies based on ursodeoxycholic acid therapy, the past experience with immunomodulating, immunosuppressing and antifibrogenic drugs and the future perspectives in which combination therapies represent a promising approach.
|Number of pages||5|
|Publication status||Published - 2001|
- Primary biliary cirrhosis
- Ursodeoxycholic acid
ASJC Scopus subject areas